Pricing
Login
Home
Charts
Search
Watchlist
Products

Trident Lifeline Ltd

TLL
₹406.05-0.96%20 Nov 2026
Reports
Pharma Formulations

Trident Lifeline Ltd

TLL
₹406.05
-0.96%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹486Cr
Close
Close Price
₹406.05
Industry
Industry
Pharma Formulations
PE
Price To Earnings
20.89
PS
Price To Sales
3.11
Revenue
Revenue
₹156Cr
Rev Gr TTM
Revenue Growth TTM
55.23%
PAT Gr TTM
PAT Growth TTM
39.53%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
71913151234243126503447
Growth YoY
Revenue Growth YoY%
-24.6126.152.266.877.879.5102.8117.346.942.850.2
Expenses
ExpensesCr
6171111825182421392536
Operating Profit
Operating ProfitCr
12244957511911
OPM
OPM%
20.012.318.926.234.525.121.921.919.822.025.224.0
Other Income
Other IncomeCr
011112125211
Interest Expense
Interest ExpenseCr
000112111112
Depreciation
DepreciationCr
001013112122
PBT
PBTCr
1334364761179
Tax
TaxCr
011110121422
PAT
PATCr
122336355757
Growth YoY
PAT Growth YoY%
-48.0-18.214.3143.8279.073.881.181.610.882.429.7
NPM
NPM%
14.88.512.218.221.618.111.816.218.113.615.014.0
EPS
EPS₹
0.91.42.02.72.46.22.74.33.75.84.35.7
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
71913151234243126503447
Growth YoY
Revenue Growth YoY%
-24.6126.152.266.877.879.5102.8117.346.942.850.2
Expenses
ExpensesCr
6171111825182421392536
Operating Profit
Operating ProfitCr
12244957511911
OPM
OPM%
20.012.318.926.234.525.121.921.919.822.025.224.0
Other Income
Other IncomeCr
011112125211
Interest Expense
Interest ExpenseCr
000112111112
Depreciation
DepreciationCr
001013112122
PBT
PBTCr
1334364761179
Tax
TaxCr
011110121422
PAT
PATCr
122336355757
Growth YoY
PAT Growth YoY%
-48.0-18.214.3143.8279.073.881.181.610.882.429.7
NPM
NPM%
14.88.512.218.221.618.111.816.218.113.615.014.0
EPS
EPS₹
0.91.42.02.72.46.22.74.33.75.84.35.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
22324587129156
Growth
Revenue Growth%
45.640.894.948.455.2
Expenses
ExpensesCr
19253672101121
Operating Profit
Operating ProfitCr
368152836
OPM
OPM%
12.419.718.417.121.822.9
Other Income
Other IncomeCr
1128108
Interest Expense
Interest ExpenseCr
001455
Depreciation
DepreciationCr
001567
PBT
PBTCr
379142732
Tax
TaxCr
-113389
PAT
PATCr
466101923
Growth
PAT Growth%
52.5-1.376.784.139.5
NPM
NPM%
18.119.013.312.115.014.8
EPS
EPS₹
6.96.25.510.216.319.4
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
22324587129156
Growth
Revenue Growth%
45.640.894.948.455.2
Expenses
ExpensesCr
19253672101121
Operating Profit
Operating ProfitCr
368152836
OPM
OPM%
12.419.718.417.121.822.9
Other Income
Other IncomeCr
1128108
Interest Expense
Interest ExpenseCr
001455
Depreciation
DepreciationCr
001567
PBT
PBTCr
379142732
Tax
TaxCr
-113389
PAT
PATCr
466101923
Growth
PAT Growth%
52.5-1.376.784.139.5
NPM
NPM%
18.119.013.312.115.014.8
EPS
EPS₹
6.96.25.510.216.319.4
Sales CAGR
1 Year48%
3 Years60%
5 Years-
TTM55%
EBITDA CAGR
1 Year89%
3 Years65%
5 Years-
TTM46%
PAT CAGR
1 Year84%
3 Years48%
5 Years-
TTM40%
Avg. ROCE
1 Year19%
3 Years16%
5 Years21%
TTM18%
CFO / EBITDA
1 Year17%
3 Years6%
5 Years-27%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
81212121212
Reserves
ReservesCr
-334405385102
Current Liabilities
Current LiabilitiesCr
81220548862
Non Current Liabilities
Non Current LiabilitiesCr
1413334169
Total Liabilities
Total LiabilitiesCr
146387156237253
Current Assets
Current AssetsCr
11495290140139
Non Current Assets
Non Current AssetsCr
313356697114
Total Assets
Total AssetsCr
146387156237253
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
81212121212
Reserves
ReservesCr
-334405385102
Current Liabilities
Current LiabilitiesCr
81220548862
Non Current Liabilities
Non Current LiabilitiesCr
1413334169
Total Liabilities
Total LiabilitiesCr
146387156237253
Current Assets
Current AssetsCr
11495290140139
Non Current Assets
Non Current AssetsCr
313356697114
Total Assets
Total AssetsCr
146387156237253

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-192-45
Investing Cash Flow
Investing Cash FlowCr
0-10-20-14-37
Financing Cash Flow
Financing Cash FlowCr
142111434
Net Cash Flow
Net Cash FlowCr
014-7-42
Free Cash Flow
Free Cash FlowCr
-1-26-16-15-29
CFO To PAT
CFO To PAT%
-5.4-315.737.5-38.024.3
CFO To EBITDA
CFO To EBITDA%
-7.9-304.027.2-26.816.7
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-192-45
Investing Cash Flow
Investing Cash FlowCr
0-10-20-14-37
Financing Cash Flow
Financing Cash FlowCr
142111434
Net Cash Flow
Net Cash FlowCr
014-7-42
Free Cash Flow
Free Cash FlowCr
-1-26-16-15-29
CFO To PAT
CFO To PAT%
-5.4-315.737.5-38.024.3
CFO To EBITDA
CFO To EBITDA%
-7.9-304.027.2-26.816.7

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
183188296320486
Price To Earnings
Price To Earnings
30.429.725.116.820.9
Price To Sales
Price To Sales
5.84.23.42.53.1
Price To Book
Price To Book
4.03.64.63.34.3
EV To EBITDA
EV To EBITDA
28.324.423.413.815.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.528.728.139.936.036.0
OPM
OPM%
12.419.718.417.121.822.9
NPM
NPM%
18.119.013.312.115.014.8
ROCE
ROCE%
43.013.213.214.819.118.1
ROE
ROE%
82.713.211.416.320.020.3
ROA
ROA%
28.59.66.86.78.29.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
183188296320486
Price To Earnings
Price To Earnings
30.429.725.116.820.9
Price To Sales
Price To Sales
5.84.23.42.53.1
Price To Book
Price To Book
4.03.64.63.34.3
EV To EBITDA
EV To EBITDA
28.324.423.413.815.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.528.728.139.936.036.0
OPM
OPM%
12.419.718.417.121.822.9
NPM
NPM%
18.119.013.312.115.014.8
ROCE
ROCE%
43.013.213.214.819.118.1
ROE
ROE%
82.713.211.416.320.020.3
ROA
ROA%
28.59.66.86.78.29.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr793782660486435402338
Close PriceClose₹147.80223.81285.00406.05762.60285.9093.41
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE278.8732.1629.2620.8915.1432.16
Price To SalesPS1.923.283.993.111.151.912.32
RevenueRevenueCr414239165156378210145
Revenue Growth TTMRev Gr TTM%13.1%13.9%55.2%19.7%27.5%6.1%
PAT Growth TTMPAT Gr TTM%-68.6%-13.6%39.5%290.6%41.9%-294.4%
Market CapitalizationMkt CapCr793782660486435402338
Close PriceClose₹147.80223.81285.00406.05762.60285.9093.41
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE278.8732.1629.2620.8915.1432.16
Price To SalesPS1.923.283.993.111.151.912.32
RevenueRevenueCr414239165156378210145
Revenue Growth TTMRev Gr TTM%13.1%13.9%55.2%19.7%27.5%6.1%
PAT Growth TTMPAT Gr TTM%-68.6%-13.6%39.5%290.6%41.9%-294.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Load More
Interviews